Zymeworks (ZYME) EBT (2021 - 2026)
Zymeworks (ZYME) reported EBT of -$46.4 million for Q1 2026, down 109.36% on a YoY basis from $495.1 million in Q1 2025, and down 11.75% sequentially from -$41.5 million in Q4 2025.
Zymeworks (ZYME) EBT (2021 - 2026) Analysis & Trends
Zymeworks (ZYME) has 6 years of EBT data on file, last reported at -$46.4 million in Q1 2026.
- For the quarter ending Q1 2026, EBT fell 109.36% year-over-year to -$46.4 million; the trailing twelve-month figure through Mar 2026 stood at -$104.0 million (up 2.99% YoY), and the FY2025 full-year result was -$79.8 million, up 31.61% from the prior year.
- EBT declined to -$46.4 million in Q1 2026, from -$41.5 million in the prior quarter.
- In the past five years, EBT ranged from a high of $320.4 million in Q4 2022 to a low of -$72.7 million in Q1 2022.
- A 5-year average of -$13.3 million and a median of -$29.6 million in 2024 frame the typical range for EBT.
- Across the five-year window, EBT jumped 890.75% in 2022 and sank 133.15% in 2025, its largest moves.
- Tracing ZYME's EBT over 5 years: stood at $320.4 million in 2022, then sank by 105.99% to -$19.2 million in 2023, then increased by 7.36% to -$17.8 million in 2024, then slumped by 133.15% to -$41.5 million in 2025, then retreated by 11.75% to -$46.4 million in 2026.
- Business Quant data shows ZYME's EBT at -$46.4 million in Q1 2026, -$41.5 million in Q4 2025, and -$18.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.31 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 259.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 438.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Zymeworks | 1.70 Bn | 1.34 Bn | - | -46.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -46.35 Mn |
| Dec 31, 2025 | -41.48 Mn |
| Sep 30, 2025 | -18.27 Mn |
| Jun 30, 2025 | 2.13 Mn |
| Mar 31, 2025 | -22.14 Mn |
| Dec 31, 2024 | -17.79 Mn |
| Sep 30, 2024 | -29.62 Mn |
| Jun 30, 2024 | -37.62 Mn |
| Mar 31, 2024 | -31.58 Mn |
| Dec 31, 2023 | -19.20 Mn |
| Sep 30, 2023 | -27.58 Mn |
| Jun 30, 2023 | -49.50 Mn |
| Mar 31, 2023 | -22.96 Mn |
| Dec 31, 2022 | 320.44 Mn |
| Sep 30, 2022 | -47.88 Mn |
| Jun 30, 2022 | -64.63 Mn |
| Mar 31, 2022 | -72.70 Mn |
| Dec 31, 2021 | -40.52 Mn |
| Sep 30, 2021 | -59.82 Mn |